CORREARD Florian
Primary tabs
Publications
http://api.archives-ouvertes.fr/search/?&fq=authLastNameFirstName_s:%28%22Correard+Florian%22%29&fl=title_s,en_title_s,docid,label_s,en_label_s,authIdHal_s,halId_s,structId_i,uri_s,keyword_s,en_keyword_s,authLastNameFirstName_s,journalTitle_s,abstract_s,en_abstract_s,producedDate_tdate,producedDateY_i,language_s&sort=publicationDate_s+desc
-
Attributes for a discrete-choice experiment on preferences of patients for oncology pharmacy consultationsSupportive Care in Cancer2024
-
Development of a sustainable to increase the bioavailability of xanthophyll-loaded nanoemulsions2024
-
Nanoémulsions de perfluorocarbures, du diagnostic au traitement du SNC2024
-
Docetaxel-loaded nanodroplets as therapeutic agents against Glioblastoma2023
-
Cytidine deaminase status as a marker of response to azacytidine treatment in MDS and AML patientsBritish Journal of Haematology2023
-
Anticancer drug delivery by focused ultrasound-mediated blood-brain/tumor barrier disruption for glioma therapy: From benchside to bedsidePharmacology and Therapeutics2023
-
Conciliation médicamenteuse : intérêts et limitesLa Revue de Médecine Interne2023
-
Tocilizumab versus anakinra in COVID-19: results from propensity score matchingFrontiers in Immunology2023
-
Molecular imaging of ultrasound-mediated blood-brain barrier disruption in a mouse orthotopic Glioblastoma ModelPharmaceutics2022
-
Acceptance, efficacy, and safety of COVID-19 vaccination in older patients with cancerJournal of Geriatric Oncology2022
-
Synthesis, In Vitro Antiproliferative Activity, and In Silico Evaluation of Novel Oxiranyl-Quinoxaline DerivativesPharmaceuticals2022
-
Docetaxel perfluorocarbon nanodroplets: a new glioblastoma therapeutic agent2022
-
Perfluorocarbon nanodroplets combined with blood-brain barrier disruption: a new therapeutic agent for glioblastoma treatment2022
-
Perfluorocarbon Nanodroplets as Potential Nanocarriers for Brain Delivery Assisted by Focused Ultrasound-Mediated Blood–Brain Barrier DisruptionPharmaceutics2022
-
Prognostic Value of the B12/CRP Index in Older Systemically Treatable Cancer PatientsCancers2022
-
Ultrasound-sensitive perfluorocarbon nanodroplets and resulting formulations: Evolution and potential for brain drug delivery2021
-
Perfluorocarbon nanodroplets and blood-brain barrier disruption as tools to improve glioblastoma treatment2021
-
Comparison of pharmacokinetics and biodistribution of laser-synthesized plasmonic Au and TiN nanoparticles2019
-
Factors Associated With COVID-19 Hospitalizations and Deaths in French Nursing HomesJournal of the American Medical Directors Association2021
-
A multipurpose integrated preclinical device for the treatment of glioblastoma2021
-
Older Patients Treated for Lung and Thoracic Cancers: Unplanned Hospitalizations and Overall SurvivalClinical Lung Cancer2021
-
Octogenarians treated for thoracic and lung cancers: Impact of comprehensive geriatric assessmentJournal of Geriatric Oncology2021
-
Centenarians in nursing homes during the COVID-19 pandemicAging2021
-
Development of a multi-functional preclinical device for the treatment of glioblastomaBiomedical optics express2021
-
Acceptability of a Novel Telemedication Review for Older Adults in Nursing Homes in France: A Qualitative StudyClinical Interventions in Aging2021
-
Medication Reconciliation Associated with Comprehensive Geriatric Assessment in Older Patients with Cancer: ChimioAge Study
Clinical Interventions in Aging2020 -
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, FranceTravel Medicine and Infectious Disease2020
-
Cellular uptake of perfluorocarbon nanodroplets: a potential nano carrier for ultrasound-mediated drug delivery2019
-
Hydrophilic Fluorescent Nanoprodrug of Paclitaxel for Glioblastoma ChemotherapyACS Omega2019
-
In vivo evaluation of safety, biodistribution and pharmacokinetics of laser-synthesized gold nanoparticles.Scientific Reports2019
